Federal Register of Legislation - Australian Government

Primary content

PB 29 of 2020 Determinations/Health as made
This instrument determines the number of therapeutic groups and the listed drugs that are in those therapeutic groups, specifically that eprosartan and losartan are the listed drugs in the angiotensin II receptor antagonist (ATRA) therapeutic group.
Administered by: Health
Registered 25 Mar 2020
Table of contents.

Commonwealth Coat of Arms of Australia

 

PB 29 of 2020

 

National Health (Pharmaceutical Benefits—Therapeutic Groups) Determination 2020

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make the following Determination under subsection 84AG(1) of the National Health Act 1953.

Dated       23   March 2020

                                 

 

 

           

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 

 

 


Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Repeal of previous instrument.................................................................................................. 1

5  Definitions................................................................................................................................ 1

6  Therapeutic Groups.................................................................................................................. 1

7  Drugs in therapeutic groups..................................................................................................... 2

Schedule 1—Therapeutic groups and listed drugs                                                    3

Part 1ATRA group                                                                                                                             3

 

 


1  Name

(1)    This instrument is the National Health (Pharmaceutical Benefits—Therapeutic Groups) Determination 2020.

(2)    This instrument may also be cited as PB 29 of 2020.

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

The whole of this instrument.

The date after this instrument is registered.

 

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under subsection 84AG(1) of the National Health Act 1953.

4  Repeal of previous instrument

                   The National Health (Pharmaceutical Benefits—Therapeutic Groups) Determination 2010 is repealed.

5  Definitions

                   In this Determination:

Act means the National Health Act 1953.

ATRA group means the Angiotensin II receptor antagonist group.

6  Therapeutic groups

For paragraph 84AG(1)(a) of the Act, a therapeutic group is a group mentioned in a Part of Schedule 1.

7  Drugs in therapeutic groups

For paragraph 84AG(1)(b) of the Act, each listed drug mentioned in a Part of Schedule 1 is in the therapeutic group mentioned in the Part.


 

Schedule 1—Therapeutic groups and listed drugs

Part 1ATRA group

Item

Listed drug

1

Eprosartan

2

Losartan